Table 3 Subsequent recurrence after treatment for loco-regional recurrence in breast cancer
From: Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy
Dose (Gy) | ||||||
|---|---|---|---|---|---|---|
All patents | <66 | ≥66 | ||||
n | % | n | % | n | % | |
Number of patients | 28 | 100.0% | 12 | 42.9% | 16 | 57.1% |
Site | ||||||
In Field | 25 | 89.3% | 10 | 35.7% | 15 | 53.6% |
Field margin | 3 | 10.7% | 2 | 7.1% | 1 | 3.6% |
Chest Wall | 19 | 67.9% | 8 | 28.6% | 11 | 39.3% |
Sternum | 2 | 7.1% | 1 | 3.6% | 1 | 3.6% |
Axilla | 6 | 21.4% | 4 | 14.3% | 2 | 7.1% |
Supraclav fossa | 6 | 21.4% | 2 | 7.1% | 4 | 14.3% |
Reconstructed breast | 3 | 10.7% | 1 | 3.6% | 2 | 7.1% |
Internal Mammary | 1 | 3.6% | 1 | 3.6% | 0 | 0.0% |
Infraclav fossa | 1 | 3.6% | 0 | 0.0% | 1 | 3.6% |
Progression during XRT | 2 | 7.1% | 1 | 3.6% | 1 | 3.6% |